Dr. Ashwini Sehgal is a nephrologist and clinical researcher, and director of an NIH-funded center grant designed to train lay people to deliver interventions in randomized controlled trials. He led several NIH-funded randomized controlled trials of pharmacologic and non-pharmacologic interventions to improve patient outcomes related to a number of complex topics, including hemodialysis leg cramps, nutritional status in renal failure, phosphorus intake among dialysis patients, adequacy of dialysis, and access to kidney transplantation. He recently completed studies that i) utilized navigators to enhance access to transplantation and ii) determined the impact of directly observed fluoxetine treatment for depression in hemodialysis patients.
Dr. Sehgal is also the Duncan Neuhauser Professor of Community Health Improvement at Case Western Reserve University, Co-Director of the Case Western Center for Reducing Health Disparities, and Associate Editor of Annals of Internal Medicine for nephrology and hypertension.